Fig. 1 · Structure

Documents & Downloads

Meldonium

Cat. No. A12316 CAS 76144-81-5

Meldonium is a cardioprotective agent. It inhibits γ-butyrobetaine hydroxylase (BBOX) and carnitine/organic cation transporter type 2 (OCTN2).

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Meldonium Research Summary

This section summarizes 1 in vitro study and 3 in vivo studies of Meldonium from 3 published references. In vitro models include primary hippocampal neurons from embryonic day 18 fetal SD rats.

Meldonium In Vitro Studies

Meldonium was evaluated in primary hippocampal neurons from fetal SD rats under OGD/R conditions. Treatment significantly enhanced neuronal viability compared with the OGD/R group, as assessed using an MTT assay. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Neuronal viability under oxygen and glucose deprivation with reperfusion

Cell-based study · primary hippocampal neurons from embryonic day 18 fetal SD rats [1]

In primary hippocampal neurons from fetal SD rats, Meldonium significantly enhanced neuronal viability under OGD/R conditions compared with the OGD/R group. Viability was assessed using an MTT assay.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
MTT assayReported result Meldonium (10 μM, 50 μM, and 100 μM) significantly enhanced neuronal viability under OGD/R condition.[1]

Literature-Reported Treatment Conditions

Treatment concentration
10 μM, 50 μM, and 100 μM
Co-treatment
Other interventions in this design: OGD/R. Compound effect isolated by the comparison: vs. the OGD/R group.
Reported limits
Not stated in the sentences used: route, schedule, vehicle.
Methods and source locations

Compound reported in the paper: Meldonium

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and methods > Assessment of cell viability (S55, S56); Results > Meldonium maintains neuronal mitochondrial function in OGD/R injury (S137, S138, S142)

MTT assay: MTT assay; comparator: OGD/R group — Results > Meldonium maintains neuronal mitochondrial function in OGD/R injury (S138)

Meldonium In Vivo Studies

In male Kunming mice, intragastric Meldonium pretreatment reduced mortality under hypoxia in a dose-dependent manner compared with hypoxia-treated saline controls. In male Sprague–Dawley MCAO rats, intravenous Meldonium significantly decreased neurological deficit scores after reperfusion compared with MCAO rats. In KPPC mice, oral Meldonium prolonged survival compared with vehicle treatment. [2,1,3]

Mortality under hypoxia in mice

Animal study · male Kunming mice; n = 8 [2]

Male Kunming mice received intragastric Meldonium pretreatment before hypoxia induction. Pretreatment reduced mortality in a dose-dependent manner compared with the hypoxia-treated saline group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Mortality rate under hypoxia exposureReported result pretreatment with meldonium reduced the mortality of mice in a dose-dependent manner[2]

Conditions shared by the study groups

Route
intragastrically
Treatment course
daily for 3 days prior to the induction of hypoxia
Vehicle
0.9% saline
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Meldonium 50 mg/kg, 100 mg/kg, 200 mg/kgthe hypoxia-treated 0.9% saline grouppretreatment with meldonium reduced the mortality of mice in a dose-dependent manner[2]
Meldonium 50 mg/kg, 100 mg/kg, 200 mg/kg
Model: male Kunming mice; n = 8
Methods and source locations

Compound reported in the paper: Meldonium

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Methods > Chemicals, reagents, and antibodies (S1); Methods > Induction of acute hypobaric hypoxia brain injury and treatment (S14, S15, S16, S17); Results > Pretreatment with meldonium rescued acute hypobaric hypoxia-induced pathological injury of brain (S91, S99)

Mortality rate under hypoxia exposure: Mortality rate under hypoxia exposure; comparator: the hypoxia-treated 0.9% saline group — Results > Pretreatment with meldonium rescued acute hypobaric hypoxia-induced pathological injury of brain (S91, S99)

Meldonium 50 mg/kg, 100 mg/kg, 200 mg/kg · Methods > Induction of acute hypobaric hypoxia brain injury and treatment (S14, S15); Results > Pretreatment with meldonium rescued acute hypobaric hypoxia-induced pathological injury of brain (S91)

Neurological deficits in MCAO rats

Animal study · Male Sprague–Dawley rats; MCAO rats [1]

In male Sprague–Dawley MCAO rats, intravenous Meldonium treatment significantly decreased neurological deficit scores after reperfusion compared with MCAO rats.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
neurological deficit score after reperfusion for 24 hReported result Treatment with 100 mg/kg, 200 mg/kg of meldonium significantly decreased NDS compared to the MCAO rats.[1]

Conditions shared by the study groups

Route
intravenously
Treatment course
1 h after ischemia and 5 h after reperfusion
Vehicle
saline
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Meldonium 100 mg/kg, 200 mg/kgsaline-treated MCAO rats (vehicle; n = 8)Treatment with 100 mg/kg, 200 mg/kg of meldonium significantly decreased NDS compared to the MCAO rats.[1]
Meldonium 100 mg/kg, 200 mg/kg
Model: Male Sprague–Dawley rats; MCAO rats
Methods and source locations

Compound reported in the paper: Meldonium

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and methods > Animals and treatment (S1, S3, S6); Materials and methods > Establishment of MCAO-induced rat cerebral ischemic injury models (S7); Results > Meldonium improves motor function and alleviates apoptosis in the cerebral cortex and hippocampus of MCAO rats (S102); Fig. 1 legend (S181)

neurological deficit score after reperfusion for 24 h: neurological deficit score after reperfusion for 24 h; comparator: saline-treated MCAO rats (vehicle; n = 8) — Results > Meldonium improves motor function and alleviates apoptosis in the cerebral cortex and hippocampus of MCAO rats (S102); Fig. 1 legend (S181)

Meldonium 100 mg/kg, 200 mg/kg · Materials and methods > Animals and treatment (S6); Results > Meldonium improves motor function and alleviates apoptosis in the cerebral cortex and hippocampus of MCAO rats (S102)

Survival in KPPC mice

Animal study · LSL-KrasG12D/+;Trp53flox/flox;Pdx-1cre/+ (KPPC) mice; C57BL/6 background [3]

KPPC mice received oral Meldonium and were followed until the humane endpoint. Meldonium-treated mice showed prolonged survival compared with vehicle-treated KPPC mice by Kaplan–Meier analysis.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
survival rateReported result meldonium-treated KPPC mice (n = 10) prolonged the survival rate compared to vehicle-treated KPPC mice (n = 14) by Kaplan-Meier analysis (p = 0.039 by log rank test; Figure 2A)[3]

Conditions shared by the study groups

Route
orally administered
Treatment course
Six-week-old KPPC mice; followed up until the humane endpoint
Vehicle
distilled water
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Meldonium 100 mg/kg/dayvehicle-treated KPPC mice (n = 14)meldonium-treated KPPC mice (n = 10) prolonged the survival rate compared to vehicle-treated KPPC mice (n = 14) by Kaplan-Meier analysis (p = 0.039 by log rank test; Figure 2A)[3]
Meldonium 100 mg/kg/day
Model: LSL-KrasG12D/+;Trp53flox/flox;Pdx-1cre/+ (KPPC) mice; C57BL/6 background
Methods and source locations

Compound reported in the paper: Meldonium

Evidence for Meldonium as the dihydrate form reported in the paper, not the free base/neutral form supplied as A12316; no salt equivalence, dose conversion or lot validation.

Results > Blocking BBOX1 inhibited PDAC and prolonged survival in mice with PDAC (S24); STAR★Methods > Experimental model and study participant details > Mouse models and animal study approval (S82, S83); STAR★Methods > Method details > Meldonium administration in vivo (S142, S143)

survival rate: survival rate; comparator: vehicle-treated KPPC mice (n = 14) — Results > Blocking BBOX1 inhibited PDAC and prolonged survival in mice with PDAC (S24)

Meldonium 100 mg/kg/day · Results > Blocking BBOX1 inhibited PDAC and prolonged survival in mice with PDAC (S24); STAR★Methods > Method details > Meldonium administration in vivo (S143)

Specifications

Manufacturer Adooq Bioscience
CAS Number 76144-81-5
Formula C6H14N2O2
Molecular Weight 146.19
Synonyms MET-88; Quaterin
SMILES
C[N+](C)(C)NCCC([O-])=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Meldonium Research References

  1. [1] Yang W, Lei X, Liu F, et al. Meldonium, as a potential neuroprotective agent, promotes neuronal survival by protecting mitochondria in cerebral ischemia-reperfusion injury. J Transl Med (2024). PMID: 39148053 DOI: 10.1186/s12967-024-05222-7 Source material
  2. [2] Liu F, He H, Yang W, et al. Novel energy optimizer, meldonium, rapidly restores acute hypobaric hypoxia-induced brain injury by targeting phosphoglycerate kinase 1. Cell Commun Signal (2024). PMID: 39075489 DOI: 10.1186/s12964-024-01757-w Source material
  3. [3] Sano M, Ijichi H, Tabata S, et al. Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer. iScience (2026). PMID: 42602712 DOI: 10.1016/j.isci.2026.117071 Source material

Added to your cart

View Cart Checkout
Loading...